WHITEGLOVEMD
Skip to content

Hypertrophic cardiomyopathy second opinion

Your Incision Should Be Your Decision™

Before choosing the next HCM treatment, make sure the decision fits your heart.

A cardiac surgeon and cardiologist independently review the same required records and imaging—then clarify the phenotype, symptoms, obstruction, medication history, anatomy, myectomy versus alcohol septal ablation, rhythm questions, and center fit.

What happens next: A member of our team will call within 2 business hours. During business hours, a same-day conversation with a cardiac surgeon or cardiologist may be arranged only when clinically appropriate and a physician is available.

2independent physician reviews1co-signed written report24 hronly after all required records and imaging are received and confirmed complete

The written review includes both physician reviews and the co-signed written report; it does not include a live physician consultation. A live consultation with one reviewing physician can be added. Pricing is shared during your complimentary discovery call.

WHITEGLOVE Insights™HCM decision review

ONE DIAGNOSIS · MULTIPLE DECISIONS

Separate the findings.
Then connect the plan.

  1. 01

    Phenotype + flowObstructive · nonobstructive · provoked

  2. 02

    Symptoms + functionWhat the findings actually explain

  3. 03

    Therapy + anatomyMedication · myectomy · ablation

  4. 04

    Rhythm + lifetime riskMonitoring · ICD · family context

Cardiac surgeonCardiologist

The direct answer

The decision is not simply whether you have HCM.

Two people with the same diagnosis can face very different questions. The obstruction may be present at rest, appear only with provocation or exercise, or not be the reason for the symptoms. Medication history, mitral anatomy, rhythm findings, family context, and the experience of the proposed center can change what deserves discussion next.

The better question: “Which finding is driving my symptoms, why is this option being recommended for me, and what reasonable alternatives fit the complete record?”

Message Us about the HCM decision

One diagnosis · six connected questions

Put the phenotype, symptoms, anatomy, and plan on the same page.

A useful HCM review separates what the record documents from what is assumed—then shows which facts support the proposed path and which questions remain open.

01

The diagnosis and phenotype

The review separates what the record supports about HCM from alternative causes of hypertrophy, then organizes obstructive or nonobstructive phenotype, wall-thickness pattern, resting and provoked gradients, and ventricular function.

02

Symptoms and function

Breathlessness, chest discomfort, fainting or near-fainting, palpitations, exercise limits, and quality of life are placed beside the findings available in the record.

03

Medication history

The report organizes which therapies were tried, the documented response, side effects, monitoring, and why another medication or procedure is now being discussed.

04

Septum and mitral anatomy

Septal thickness, systolic anterior motion, regurgitation mechanism, papillary muscles, chordae, coronary disease, and other anatomy can change the procedural question.

05

Rhythm and device questions

The review organizes documented HCM-related family history, suspected arrhythmic syncope, massive wall thickness, ejection fraction below 50%, apical aneurysm, nonsustained ventricular tachycardia, and extensive MRI scar without treating them as equivalent checklist items.

06

Center and operator fit

HCM-specific procedures require experienced teams. Program experience, imaging quality, procedure-specific expertise, and longitudinal follow-up belong in the comparison.

Medication, myectomy, or ablation

The options are not interchangeable—and the sequence matters.

For symptoms attributed to obstructive HCM, the choice among continued medical therapy, a cardiac myosin inhibitor, disopyramide, septal myectomy, alcohol septal ablation, or further evaluation depends on the documented response, mechanism, anatomy, comorbidity, priorities, and HCM-specific expertise.

01Medical pathway

Continue, change, or escalate medication

For symptomatic obstructive HCM, current guidance places beta-blockers or nondihydropyridine calcium-channel blockers before additional options such as a cardiac myosin inhibitor, disopyramide, or septal reduction in appropriate patients. The record should show what was tried, what changed, and what remains limiting.

Questions the record should answer
  • Are the symptoms attributable to outflow obstruction?
  • Were prior therapies tolerated and assessed adequately?
  • What monitoring or contraindications matter for the option proposed?
02Surgical septal reduction

Septal myectomy

Myectomy removes part of the thickened septum and can allow associated mitral, subvalvular, coronary, or other cardiac disease to be addressed surgically when needed. Current guidance recommends myectomy when associated cardiac disease also needs surgical treatment. Anatomy, the complete operative plan, center experience, and recovery burden matter.

Questions the record should answer
  • Does associated anatomy need surgical treatment?
  • What exactly would the operation include?
  • How much HCM and myectomy experience does the program have?
03Catheter-based septal reduction

Alcohol septal ablation

Alcohol septal ablation uses a selected septal artery to reduce the tissue contributing to obstruction. Current guidance supports it for eligible adults with severe symptoms when surgery is contraindicated or carries unacceptable risk because of serious comorbidity or advanced age. Coronary anatomy, rhythm tradeoffs, local expertise, and associated disease still matter.

Questions the record should answer
  • Does the septal blood supply support a targeted ablation?
  • What are the conduction and pacemaker tradeoffs?
  • Would associated mitral or coronary disease remain untreated?
For eligible patients with symptoms attributable to obstructive HCM despite appropriate medical therapy, septal reduction should be considered and performed through an experienced HCM program.WHITEGLOVEMD provides educational decision support. It does not diagnose HCM, prescribe medication, determine candidacy, select a procedure or device, or replace the treating clinicians.
Message Us about the options

WHITEGLOVE Heart Team

The procedural view and the longitudinal cardiology view—on the same record.

A cardiac surgeon and cardiologist review independently, then confer and co-sign one patient-facing report.

01

Cardiac surgeon

Reviews septal, mitral, papillary-muscle, chordal, aortic-valve, and coronary anatomy; the scope of myectomy; associated procedures; operative burden; and program experience.

WHITEGLOVE Insights™One co-signed reportIndependent reviews · physician conference · patient-facing explanation
02

Cardiologist

Reviews phenotype, symptoms, gradients, medication response, imaging, rhythm, device questions, genetics, family context, functional testing, and reasonable alternatives.

Meet the full team

WHITEGLOVE Insights™

A patient-facing HCM report built around the decision—not a generic summary.

The report connects the source record, current guidance, two physician perspectives, evidence limits, options, and next questions without issuing a remote treatment order.

See a sample report
WHITEGLOVE Insights™HCM decision review

DECISION FOCUS

Which finding should drive the next step?

01Phenotype + symptomsRest · provocation · function02Anatomy + optionsMedication · myectomy · ablation03Rhythm + next questionsRisk · device · lifetime care
Cardiac surgeonCardiologist
01

Your current HCM picture

Phenotype, symptoms, gradients, anatomy, rhythm history, imaging, prior therapy, and the treating team’s proposed plan—clearly source-linked.

02

What the evidence supports

The current guideline context that applies to the documented symptoms, obstruction, medication history, imaging, arrhythmia, and procedural question.

03

Options and tradeoffs

The reasons medication, a myosin inhibitor, myectomy, alcohol septal ablation, rhythm treatment, further testing, or surveillance may be under discussion.

04

Anatomy that changes the choice

When relevant, septal, mitral, papillary-muscle, chordal, aortic-valve, and coronary findings are connected to the proposed path.

05

Risk and device context

Documented sudden-death risk markers and additional modifiers are organized without treating one score or finding as an automatic ICD decision.

06

Questions and next steps

Missing records, unresolved findings, center-experience questions, and practical next conversations to bring back to the clinicians responsible for your care.

What may be needed

The review is only as complete as the record behind it.

A missing study does not automatically mean the prior care was inadequate. It means the limit of the available review should be visible—and turned into a useful question for the treating team.

01

Source echocardiography

The actual study and report, including septal thickness, resting and provoked gradients, systolic anterior motion, mitral regurgitation, chamber size, and ventricular function.

02

Exercise or provocation data

When symptoms and resting findings do not align, available exercise echo or other provocative assessment may clarify dynamic obstruction and functional limitation.

03

Cardiac MRI

When performed, MRI may add wall-thickness distribution, apical anatomy, ventricular function, aneurysm, scar, and alternative-diagnosis context.

04

Rhythm information

ECGs, ambulatory monitoring, atrial or ventricular arrhythmia, syncope history, and any pacemaker or defibrillator records.

05

Medication and response history

Which therapies were tried, at what doses, for how long, what changed, and whether side effects or other conditions limited the options.

06

Family and genetic context

A three-generation family history when available, previous genetic testing or counseling, and the screening plan already discussed with the treating team.

Begin in writing

Start with two physician reviews. Add one live physician conversation only if you want it.

The written-review plan is the complete written review without a live physician consultation. The Consult plan adds one live consultation with one reviewing physician.

Written review

WHITEGLOVE Insights™

Two independent physician reviews plus one co-signed written report. No live physician consultation.

  • Cardiac surgeon review
  • Cardiologist review
  • One co-signed written report
  • No live physician consultation
View this plan

The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.

How it works

From a difficult HCM question to a documented next conversation.

One coordinated, virtual process—with records support available and a clear start to the 24-hour review window.

  1. 01

    Message us in your own words

    Tell us what you were told, what treatment or device is being discussed, and what still feels unresolved. No referral or complete record is required to send the first message.

  2. 02

    We help identify what is needed

    Upload what you have. With your authorization, the records team can help identify and request the relevant notes, reports, required imaging, rhythm data, and treatment history.

  3. 03

    Two physicians review independently

    A cardiac surgeon and cardiologist review the same required records and imaging independently, then confer.

  4. 04

    Receive one co-signed written report

    The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window. Both reviewing physicians co-sign the patient-facing report.

Current published framework

Guidelines inform the review. They do not make the individual decision.

The current US HCM guideline emphasizes shared decision-making and experienced multidisciplinary care for complex treatment choices. Population guidance and risk estimates still require complete inputs and clinical interpretation.

Current clinical guideline

2024 AHA/ACC multisociety HCM guideline

The current guideline emphasizes shared decision-making, multidisciplinary HCM centers for complex decisions, updated medical therapy, experienced-center septal reduction, rhythm risk, family history, and genetics.

American College of Cardiology
Patient decision context

Key patient messages from the 2024 guideline

The patient guidance explains why personal goals, multidisciplinary expertise, exercise counseling, myosin inhibitors, atrial fibrillation, and shared decisions belong in HCM care.

American Heart Association
Guideline summary

Key points for HCM evaluation and management

The summary covers obstruction assessment, medical and procedural options, experienced-center care, family evaluation, rhythm monitoring, imaging, and sudden-death risk conversations.

American College of Cardiology

Frequently asked questions

Questions patients and families ask before an HCM treatment or device decision.

Direct answers without pretending the same pathway fits every person with HCM.

When is an HCM second opinion useful?

A second opinion can be useful when the diagnosis or phenotype remains uncertain, symptoms and resting tests do not align, a medication or septal reduction procedure has been proposed, myectomy and alcohol septal ablation are being compared, mitral treatment is under discussion, or sudden-death risk and an ICD decision feel unresolved. It should not delay urgent or time-sensitive care directed by the treating team.

What is the difference between obstructive and nonobstructive HCM?

In obstructive HCM, blood leaving the left ventricle encounters a dynamic outflow obstruction, often involving the septum and systolic anterior motion of the mitral valve. In nonobstructive HCM, hypertrophy is present without that outflow gradient under the conditions tested. Symptoms and treatment questions can occur in either phenotype, and obstruction may require provocation or exercise to detect.

Will the review compare medication with septal reduction?

Yes, when that is the decision documented in the record. The report can organize prior medication trials, symptoms, gradients, anatomy, functional testing, comorbidities, and the reasons continued medical therapy, a cardiac myosin inhibitor, disopyramide, myectomy, alcohol septal ablation, or further evaluation may be under discussion. It does not prescribe a drug or select a procedure.

How do septal myectomy and alcohol septal ablation differ?

Myectomy is open-heart surgery that removes part of the thickened septum and can address associated mitral, subvalvular, coronary, or other cardiac disease when needed. Alcohol septal ablation is a catheter-based procedure that uses a selected septal artery to reduce tissue causing obstruction. Anatomy, associated disease, comorbidity, local expertise, and personal priorities affect the comparison; not every patient is a candidate for either approach.

Why does mitral regurgitation matter in obstructive HCM?

Mitral regurgitation in HCM may result from systolic anterior motion, intrinsic leaflet disease, papillary-muscle or chordal anatomy, or more than one mechanism. The mechanism can affect whether relieving septal obstruction may address the leakage or whether a separate mitral strategy deserves discussion.

Will the report tell me whether I need an ICD?

No. An ICD is a shared clinical decision, not an automatic result from one score or finding. The review can organize documented major risk markers and additional modifiers alongside device burdens, competing risks, personal priorities, and unanswered questions for the HCM and electrophysiology teams.

Will the review consider cardiac MRI, rhythm monitoring, or exercise testing?

Yes, when those studies are relevant and available. MRI can add anatomy and scar context, rhythm monitoring can identify atrial or ventricular arrhythmia, and exercise testing can clarify functional limitation or dynamic obstruction. The report identifies material gaps without implying that every patient requires every test.

Who reviews my HCM case?

A cardiac surgeon and cardiologist independently review the same required records and imaging, then confer and co-sign one WHITEGLOVE Insights™ report. The written-review plan includes both physician reviews and the report but no live physician consultation. The Consult plan adds one live consultation with one reviewing physician.

What records are needed for an HCM second opinion?

The exact record depends on the question. It commonly includes source echocardiograms, cardiac MRI when performed, exercise or stress testing, ECGs and rhythm-monitor reports, clinical notes, medication history and response, laboratory results, family and genetic context, device records when applicable, and the proposed treatment plan. With authorization, the records team can help identify and request what is needed.

When does the 24-hour report window begin?

The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.

Can I speak live with a reviewing physician?

Yes. The WHITEGLOVE Consult plan includes everything in the written review plus one live consultation with one reviewing physician. The written-review plan does not include a live physician consultation.

What if my symptoms may be an emergency?

Do not wait for an online review. Call 911 or seek immediate emergency care for fainting, new or severe chest pain, severe breathing difficulty, a sustained rapid heartbeat, cardiac-arrest symptoms, stroke symptoms, or rapid worsening. WHITEGLOVEMD is not an emergency service, and a records review should never delay urgent evaluation or treatment.

The decision stays yours

Bring the whole HCM record to one Heart Team before choosing the next step.

Tell us what was proposed, what is already scheduled, and what still feels unresolved. You do not need every record—or the right medical words—to begin.

What happens next: A member of our team will call within 2 business hours. During business hours, a same-day conversation with a cardiac surgeon or cardiologist may be arranged only when clinically appropriate and a physician is available.